Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy

Conditions: Carbon Monoxide Poisoning, Carbon Monoxide Intoxication, Carbon Monoxide Encephalopathy, Carbon Monoxide-induced Parkinsonism

Sex: All

Ages: 19 Years – N/A

Healthy volunteers: No

Phase: PHASE1, PHASE2

Enrollment: 20

Sponsor: University of Nebraska

Location: Nebraska Medicine, Hyperbaric Medicine Program, Clarkson Tower Omaha Nebraska

Summary

Hyperbaric Oxygen Therapy (HBO) is routine treatment of carbon monoxide (CO) poisoning to prevent delayed neurological sequelae. This study looking to see if neurologic outcomes are improved with the addition of dexamethasone. CO poisoning can initiate a free radical mediated process that can instigate a demyelinating process resulting in long term neurological sequelae in some, but not all patients. In other demyelinating disorders, steroids are a part of first line treatment. HBO is already used for acute CO poisoning, so this pilot study will try to ascertain if the addition of steroids in concert with each hyperbaric oxygen session will yield improved outcomes.

Eligibility Criteria

Inclusion Criteria: * Acute CO poisoning, intentional or non-intentional exposure, receiving HBO treatment during hospitalization * Age \>18 years * Nebraska Medicine admission Exclusion Criteria: * Mechanical ventilation * No hospital admission or admission to hospital Critical Care Medicine Service * Allergy to dexamethasone * Pre-Existing neurological condition confounding outcome determination

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06574048). StuddyBuddy aggregates publicly available trial information.